# South Korea Viral Clearance Market > South Korea Viral Clearance Market Research Report By Method (Viral Removal Method, Viral Inactivation Method, Viral Detection Method), By Application (Blood and Blood Products, Recombinant Proteins, Cellular & Gene Therapy Products, Vaccines, Others) and By End-user (Pharmaceutical and Biotech Industry, Academic Research Institutes, CROs, Others) -Forecast to 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 22.0% - **2024:** $ 17.6 Million - **2025:** $ 21.47 Million - **2035:** $ 156.8 Million - **Key Players:** Sartorius (DE), Merck KGaA (DE), Thermo Fisher Scientific (US), Charles River Laboratories (US), Lonza Group (CH), Boehringer Ingelheim (DE), Fujifilm Diosynth Biotechnologies (GB), KBI Biopharma (US) **Report ID:** MRFR/HC/50091-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-viral-clearance-market-51849 --- ## Market Summary ## **South Korea Viral Clearance Market Overview** As per MRFR analysis, the South Korea Viral Clearance Market Size was estimated at 10.8 (USD Million) in 2024.The South Korea Viral Clearance Market Industry is expected to grow from 13.2(USD Million) in 2025 to 196 (USD Million) by 2035. The South Korea Viral Clearance Market CAGR (growth rate) is expected to be around 27.796% during the forecast period (2025 - 2035). **Key South Korea Viral Clearance Market Trends Highlighted** The South Korea Viral Clearance Market is witnessing significant trends driven by the growing focus on biopharmaceutical safety and regulatory compliance. With the increasing emphasis on the need for effective viral clearance processes in bioprocessing, there is heightened investment in advanced technologies and methodologies. South Korea's government has been supportive of the biotechnology sector, implementing stringent regulations to ensure the safety and efficacy of biopharmaceutical products. This regulatory environment fosters innovation and drives companies to adopt more efficient viral clearance techniques, including robust virology testing and filtration technologies.Opportunities exist in the form of collaborations between biopharmaceutical companies and research institutions. South Korea boasts a strong research base, particularly in the fields of life sciences and healthcare technology. Leveraging this research base can accelerate the development of new viral clearance solutions tailored to local market needs. Additionally, the rise of personalized medicine and regenerative therapies presents unique challenges in viral contamination risk management, creating a demand for specialized viral clearance services. Recently, there has been a trend toward integrating automation and digital solutions within the viral clearance landscape.Companies are exploring automation not just to enhance efficiency but also to maintain high standards of safety, vital for regulatory approval. The COVID-19 pandemic has further emphasized the importance of viral clearance, prompting substantial interest in ensuring product safety in future biopharmaceutical development. The South Korean market is thus positioned to experience growth driven by both technological advancements and a proactive regulatory framework, leading to enhanced safety measures while exploring new therapeutic avenues. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **South Korea Viral Clearance Market Drivers** **Increasing Biopharmaceutical Research and Development Activities** The South Korea Viral Clearance Market Industry is witnessing a significant rise in Research and Development activities in the biopharmaceutical sector. According to the Korea National Enterprise for Clinical Trials, in recent years, there has been a reported annual increase of approximately 15% in the number of biopharmaceutical companies conducting clinical trials in South Korea. This surge is attributed to favorable government policies that support biotechnological advancements, including funding programs and tax incentives aimed at enhancing innovation. Major companies like Samsung Biologics and Celltrion are leading this charge by heavily investing in R&D, which ultimately drives the demand for effective viral clearance solutions to ensure their products meet stringent regulatory standards. As the biopharmaceutical industry continues to expand, the need for viral clearance will increase proportionally, thus promoting South Korea's position in the global market. In fact, the rapid development of therapeutic biologics necessitates robust viral clearance methods to ensure patient safety, aligning with the country's goal to become a key player in the global biotech market. **Proliferation of Infectious Diseases and Health Crises** The occurrences of infectious diseases in South Korea have accelerated the demand for the Viral Clearance Market Industry. The Korea Centers for Disease Control and Prevention (KCDC) indicated a considerable rise in investments towards advanced viral detection and clearance technologies as part of the nation's public health strategy. In response to the pandemic, local manufacturers like SK Bioscience have ramped up their focus on developing vaccines and therapeutics, consequently increasing the need for stringent viral clearance solutions. This shift in focus is expected to continue, as public health preparedness remains a crucial concern for the South Korean government, thereby driving growth in the viral clearance sector. **Regulatory Reforms and Stringent Safety Standards** The South Korea Viral Clearance Market Industry is significantly influenced by the implementation of stringent regulatory frameworks for the biopharmaceutical sector. The Ministry of Food and Drug Safety (MFDS) has introduced regulations demanding enhanced safety measures in drug production, particularly concerning viral infections. According to the MFDS, adherence to these regulations is anticipated to grow as they seek to align with global standards established by organizations like the World Health Organization. This has resulted in a substantial increase in the investment among local and international biopharmaceutical companies in viral clearance technologies. Estimations suggest an approximate increase of 20% in the adoption of viral clearance processes to comply with these evolving regulatory standards, reflecting a strong market demand driven by the obligation to meet national safety regulations and enhance public trust in biopharmaceutical products. **Rising Demand for Advanced Therapies** The emergence of advanced therapeutic modalities, including gene therapies and cell therapies, is propelling the growth of the South Korea Viral Clearance Market Industry. These innovative treatments demand high safety assurances, necessitating rigorous viral clearance processes to avoid potential contamination. In line with this trend, the Ministry of Health and Welfare reported a 30% year-over-year increase in the development of cell and gene therapies, reflecting growing investment in these areas. The need and demand for efficient viral clearance techniques in high-precision medical products is constantly increasing. This is due to safety having become a priority, along with improved therapeutic methods. Companies like Therapix Biosciences are merging therapies with advanced methods of viral clearance and developing new approaches for these issues. **South Korea Viral Clearance Market Segment Insights** **Viral Clearance Market Method Insights** The South Korea Viral Clearance Market is rapidly evolving, with the 'Method' segment playing a crucial role in ensuring the safety and efficacy of biopharmaceutical products. The market, expected to witness substantial growth, highlights the importance of different approaches for viral clearance, namely, Viral Removal Method, Viral Inactivation Method, and Viral Detection Method. Each method serves a distinct purpose in safeguarding public health and ensuring compliance with stringent regulatory frameworks in South Korea. Viral Removal Methods primarily utilize filtration and chromatography techniques to eliminate harmful viruses from biopharmaceuticals, making them essential for products such as vaccines and immunoglobulins. The growing focus of the South Korea pharmaceutical industry on high-quality production is anticipated to enhance the adoption of these methodologies significantly. Conversely, Viral Inactivation Methods utilize physical or chemical means to deactivate viral particles, ensuring that any residual pathogens are rendered harmless. This is especially pertinent as the demand for safe blood products and biologics continues to rise, fueled by South Korea's aging population and increasing healthcare needs. Moreover, the Viral Detection Method segment is vital for confirming the presence of viral contaminants in production processes. With South Korean regulatory bodies emphasizing rigorous testing and validation, the prominence of this method is expected to increase. Overall, the South Korea Viral Clearance Market shows a dynamic interplay between these methods, driven by technological advancements and increasing awareness of viral safety in the biopharmaceutical domain. The concerted efforts from the government and private sectors to boost biotechnological innovation will likely contribute to the effective implementation of these viral clearance methods, ultimately ensuring public health safety. The integration of cutting-edge technologies and strict regulatory compliance is set to position South Korea as a leader in viral clearance methodologies, further solidifying its role in global health initiatives. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Viral Clearance Market Application Insights** The Application segment of the South Korea Viral Clearance Market plays a crucial role in ensuring the safety and efficacy of various biopharmaceuticals and medical products. Key applications include Blood and Blood Products, which are vital for transfusions and surgical procedures, underscoring the need for stringent viral clearance processes. Recombinant Proteins are significant in therapeutic applications, driving innovation in treatments for chronic diseases. Cellular and Gene Therapy Products present unique challenges in viral clearance due to their intricate nature, thereby necessitating advanced techniques.Vaccines are another essential component, as the growing focus on immunization drives the demand for reliable viral clearance methods. Additionally, the Others category captures emerging applications that may leverage viral clearance technologies. The South Korea Viral Clearance Market is influenced by an increasing focus on patient safety, regulatory standards, and technological advancements, presenting opportunities for growth across these applications. With a robust research infrastructure and emphasis on biopharmaceutical development, South Korea is poised to improve viral clearance methodologies, benefiting public health and industry standards. **Viral Clearance Market End-user Insights** The South Korea Viral Clearance Market is experiencing robust growth, particularly in the End-user segment, which includes key players such as the Pharmaceutical and Biotech Industry, Academic Research Institutes, Clinical Research Organizations (CROs), and Others. The Pharmaceutical and Biotech Industry is a significant driver of this market, as these sectors increasingly rely on viral clearance processes to ensure product safety and regulatory compliance. Academic Research Institutes contribute through extensive Research and Development activities aimed at advancing viral clearance technologies, fostering innovation in therapeutic solutions. CROs play a crucial role by providing essential testing and consulting services, making them integral to the operational framework of the industry. Furthermore, the growing demand for biopharmaceuticals and the rising prevalence of infectious diseases are generating opportunities across these segments. The South Korean government has been promoting biotechnology as a strategic industry, aligning with global trends and boosting investment, which adds to the market's potential for growth. Collectively, the dynamics in these End-user areas create a multifaceted landscape, reflecting the importance of viral clearance in enhancing public health safety and pharmaceutical efficacy. **South Korea Viral Clearance Market Key Players and Competitive Insights** The South Korea Viral Clearance Market has witnessed significant growth and development in recent years, driven by increasing demand for effective viral removal and inactivation technologies in biopharmaceutical manufacturing. This sector has become crucial as industries recognize the importance of ensuring the safety and efficacy of biological products. Companies operating within this market are continuously innovating and expanding their service offerings to meet stringent regulatory requirements and consumer expectations. The competitive landscape is characterized by a surge in research and development efforts, collaborations, and partnerships aimed at enhancing viral clearance solutions. As entities strive to position themselves as leaders in this domain, market participants are focusing on technology advancements, quality assurance, and comprehensive service portfolios that cater to a variety of applications, including vaccines, monoclonal antibodies, and cell and gene therapies.SK Bioscience stands out in the South Korea Viral Clearance Market due to its robust research and development capabilities and strong emphasis on innovation. The company has established itself as a significant player by leveraging its cutting-edge technologies to develop viral clearance products that meet high international standards. With a commitment to quality and safety, SK Bioscience has successfully implemented a range of viral inactivation processes tailored for the biopharmaceutical industry. The company’s strategic investments in state-of-the-art manufacturing facilities have further enhanced its market presence, enabling it to respond effectively to the growing demand for viral clearance solutions. Additionally, SK Bioscience’s partnerships with various academic and research institutions bolster its position in the market, facilitating access to the latest findings and technologies that enhance its product offerings.Celltrion is another key player in the South Korea Viral Clearance Market, known for its comprehensive approach to biopharmaceutical development that includes a strong focus on viral clearance processes. The company offers a variety of key products and services that align with industry standards for safety and efficacy, particularly in the development of monoclonal antibodies and biosimilars. Celltrion's market presence is strengthened by its innovative manufacturing capabilities and a commitment to maintaining regulatory compliance. The company has successfully executed mergers and acquisitions that have expanded its technological base and service capabilities, allowing it to cover an extensive range of viral clearance needs in the region. Through its strategic initiatives, Celltrion continues to enhance its competitive edge in the market, thereby contributing significantly to the advancement of safe and effective biopharmaceutical solutions in South Korea. **Key Companies in the South Korea Viral Clearance Market Include** - SK Bioscience - Celltrion - Daewoong Pharmaceutical - Hanmi Pharmaceutical - Hugel - Samsung Biologics - LG Chem - AhnGook Pharmaceutical - Daewon Pharmaceutical - Medytox - Boryung Pharmaceutical - Korea Vaccine - SillaJen - Green Cross - Genexine **South Korea Viral Clearance Market Industry Developments** The South Korea Viral Clearance Market has witnessed notable developments recently, particularly among key players such as SK Bioscience, Celltrion, and Samsung Biologics. In September 2023, SK Bioscience announced a partnership with Korea Vaccine to enhance their Research and Development capabilities, focusing on viral clearance technologies. Meanwhile, Celltrion is expanding its production capacity to meet the growing demand for biopharmaceuticals, further influencing market dynamics. Additionally, in July 2023, Medytox and Hanmi Pharmaceutical entered a strategic agreement to collaborate on innovative viral treatments, which is expected to bolster their market presence. In terms of mergers and acquisitions, Boryung Pharmaceutical announced in August 2023 their acquisition of Genexine’s antiviral program, aimed at advancing their product pipeline. The South Korean government continues to support the sector through funding initiatives and grants, driving growth in market valuation and setting a favorable regulatory environment for companies like LG Chem and Hugel to innovate and invest. The last two to three years have seen increased focus on bioprocessing improvements and novel viral clearance solutions amid the ongoing emphasis on public health safety, reshaping the competitive landscape of the market. **South Korea Viral Clearance Market Segmentation Insights** **Viral Clearance Market Method****Outlook** - Viral Removal Method - Viral Inactivation Method - Viral Detection Method **Viral Clearance Market Application****Outlook** - Blood and Blood Products - Recombinant Proteins - Cellular & Gene Therapy Products - Vaccines - Others **Viral Clearance Market End-user****Outlook** - Pharmaceutical and Biotech Industry - Academic Research Institutes - CROs - Others ## Market Drivers ### Increased Investment in R&D Investment in research and development (R&D) within the biopharmaceutical sector is a significant driver for the viral clearance market. South Korea has been actively promoting innovation through various government initiatives, leading to an increase in funding for R&D activities. In 2025, R&D expenditure in the life sciences sector is expected to exceed $5 billion, reflecting a commitment to advancing healthcare technologies. This influx of capital is likely to foster the development of novel viral clearance methods and technologies, enhancing the overall efficiency and effectiveness of the viral clearance market. As companies strive to develop cutting-edge therapies, the demand for robust viral clearance processes will continue to rise, ensuring that products meet the highest safety standards. ### Stringent Regulatory Frameworks The presence of stringent regulatory frameworks in South Korea significantly influences the viral clearance market. Regulatory bodies, such as the Ministry of Food and Drug Safety (MFDS), enforce rigorous guidelines to ensure the safety and efficacy of biopharmaceutical products. Compliance with these regulations is crucial for manufacturers, as failure to adhere can result in severe penalties and product recalls. In 2025, the MFDS is expected to implement even more stringent guidelines, further emphasizing the importance of effective viral clearance processes. This regulatory landscape drives the viral clearance market to innovate and adopt advanced technologies that can meet these evolving standards, thereby ensuring product safety and maintaining public trust. ### Emergence of Advanced Technologies The emergence of advanced technologies in the field of viral clearance is a notable driver for the market. Innovations such as nanofiltration, chromatography, and viral inactivation methods are revolutionizing the way manufacturers approach viral clearance. In South Korea, the adoption of these technologies is expected to increase significantly, with the market projected to grow at a CAGR of 8% from 2025 to 2030. This growth is indicative of the viral clearance market's responsiveness to technological advancements that enhance efficiency and effectiveness. As manufacturers seek to optimize their production processes and ensure compliance with safety regulations, the integration of these advanced technologies will likely become a standard practice, further driving market growth. ### Rising Demand for Biopharmaceuticals The increasing demand for biopharmaceuticals in South Korea is a key driver for the viral clearance market. As the biopharmaceutical sector expands, the need for effective viral clearance processes becomes paramount to ensure product safety and efficacy. In 2025, the biopharmaceutical market in South Korea is projected to reach approximately $10 billion, indicating a robust growth trajectory. This surge necessitates advanced viral clearance technologies to mitigate contamination risks. The viral clearance market is thus positioned to benefit from this trend, as manufacturers seek to comply with stringent safety regulations and maintain consumer trust. Furthermore, the growing prevalence of chronic diseases and the aging population in South Korea are likely to further fuel the demand for biopharmaceuticals, thereby enhancing the need for reliable viral clearance solutions. ### Growing Awareness of Safety Standards There is a growing awareness of safety standards among consumers and healthcare professionals in South Korea, which is driving the viral clearance market. As patients become more informed about the risks associated with biopharmaceuticals, they increasingly demand transparency regarding the safety measures implemented during production. This heightened awareness compels manufacturers to invest in robust viral clearance processes to ensure their products are free from viral contaminants. The viral clearance market is thus likely to see increased demand for advanced technologies that can provide reliable assurance of product safety. In 2025, consumer expectations regarding safety are anticipated to rise, further propelling the need for effective viral clearance solutions. ## Future Outlook The [Viral clearance market](https://www.marketresearchfuture.com/reports/viral-clearance-market-11268) is projected to grow at a 22.0% CAGR from 2025 to 2035, driven by increasing regulatory demands and advancements in biopharmaceutical technologies. **New opportunities:** - Development of advanced viral filtration systems for bioprocessing applications. - Investment in automated viral testing platforms to enhance efficiency. - Partnerships with biotech firms for innovative viral clearance solutions. By 2035, the market is expected to achieve substantial growth, positioning itself as a leader in biopharmaceutical safety. ## Segment Insights ### By Method: Viral Removal Method (Largest) vs. Viral Inactivation Method (Fastest-Growing) In the South Korea viral clearance market, the segment values are dominated by Viral Removal Method, which maintains a significant market share. This method's established techniques and technological advancements have made it a preferred choice among manufacturers. Meanwhile, the Viral Inactivation Method, although currently smaller in market share, is gaining traction due to its effectiveness and the increasing demand for safer and more reliable viral clearance processes. The growth trends in the method segment reveal that Viral Inactivation Method is on an upward trajectory, driven by regulatory frameworks favoring safer processes, and advancements in technology enhancing efficacy. The shift towards stringent quality controls and the rising need for preventative measures against viral contamination are pushing the market further. These drivers indicate a promising future for the Viral Inactivation Method as it becomes more adopted across various industries, complemented by innovation and increased investment in research and development. Viral Removal Method (Dominant) vs. Viral Inactivation Method (Emerging) Viral Removal Method is recognized as the dominant force within the South Korea viral clearance market, characterized by well-established processes and proven effectiveness in eliminating viral contaminants from products. This method, widely adopted across the pharmaceutical and bioprocessing industries, is known for its reliability and efficiency. In contrast, the Viral Inactivation Method stands as an emerging player, gaining momentum due to its ability to inactivate viruses without the need for physical removal. This method appeals to manufacturers looking for innovative solutions to meet evolving regulatory standards while maintaining product integrity. As both methods evolve, they showcase a balance of traditional and innovative approaches to viral clearance. ### By Application: Blood and Blood Products (Largest) vs. Vaccines (Fastest-Growing) The South Korea viral clearance market exhibits a dynamic landscape regarding application segments. Among these, Blood and Blood Products stand out as the largest segment, commanding significant market share due to rising demands in transfusion procedures and the increasing prevalence of blood-related disorders. Conversely, Vaccines are capturing attention as the fastest-growing segment, driven by heightened public health initiatives and the ongoing development of innovative vaccine technologies, which are elevating their market presence. Growth trends in this market segment are influenced by several key factors. The expansion of advanced therapeutic products like Cellular & Gene Therapy Products indicates a surge in research and development activities. Meanwhile, the emphasis on the safety and efficacy of viral clearance methods is pushing manufacturers to adopt sophisticated technologies. The overall strategic focus on improving patient outcomes ensures robust growth prospects across the diverse applications within the South Korea viral clearance market. Blood and Blood Products (Dominant) vs. Vaccines (Emerging) Blood and Blood Products dominate the application spectrum within the South Korea viral clearance market, primarily due to their critical role in medical treatments and emergency care. This segment benefits from a well-established infrastructure for blood collection, processing, and distribution, ensuring its steady demand. On the other hand, Vaccines represent an emerging segment, propelled by increased public health awareness and frequent outbreaks of vaccine-preventable diseases. This segment is characterized by rapid technological advancements, allowing for faster development and deployment of vaccines, which is crucial in countering health crises. The contrast between these segments highlights a clear distinction in market maturity and growth potential. ### By End-user: Pharmaceutical and Biotech Industry (Largest) vs. Academic Research Institutes (Fastest-Growing) In the South Korea viral clearance market, the distribution of market share among various end-users reveals that the pharmaceutical and biotech industry holds a significant portion, which underscores its critical role in drug development and production processes. Academic research institutes follow as a notable segment, showcasing their increasing reliance on viral clearance methods for emerging research and innovations. Other end-users, including CROs and miscellaneous entities, contribute to market dynamics but are comparatively smaller in share. The growth trends within this segment indicate that the pharmaceutical and biotech industry is solidifying its dominance due to ongoing advancements in drug manufacturing techniques and stringent regulatory requirements. Meanwhile, academic research institutes are emerging as the fastest-growing segment, driven by increasing investments in research activities and collaborations aimed at addressing viral threats. The rising emphasis on research funding and the need for safe and effective vaccine development further bolster their growth trajectory. Pharmaceutical and Biotech Industry (Dominant) vs. Academic Research Institutes (Emerging) The pharmaceutical and biotech industry stands as the dominant force in the South Korea viral clearance market, characterized by its extensive investment in innovative technologies and robust quality control measures for product safety. This sector benefits from established relationships with regulatory bodies, enabling streamlined approval processes for new therapies. On the other hand, academic research institutes are rapidly emerging, fueled by a heightened focus on viral research and a surge in public health initiatives. These institutions often collaborate with the pharmaceutical sector, leveraging their research capabilities to contribute to vaccine development and outbreak preparedness. The synergy between these segments is shaping the market and addressing the growing demand for effective viral clearance solutions. ## Competitive Benchmarking The viral clearance market in South Korea is characterized by a dynamic competitive landscape, driven by increasing demand for biopharmaceuticals and stringent regulatory requirements. Key players such as Sartorius (DE), Merck KGaA (DE), and Thermo Fisher Scientific (US) are strategically positioned to leverage innovation and technological advancements. Sartorius (DE) focuses on enhancing its product portfolio through continuous R&D, while Merck KGaA (DE) emphasizes strategic partnerships to expand its market reach. Thermo Fisher Scientific (US) adopts a customer-centric approach, tailoring solutions to meet specific client needs, thereby shaping a competitive environment that prioritizes innovation and responsiveness.In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. The market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies like Lonza Group (CH) and Charles River Laboratories (US) suggests a trend towards consolidation, as these firms seek to enhance operational efficiencies and broaden their service offerings. In October Lonza Group (CH) announced the opening of a new viral clearance facility in South Korea, aimed at increasing its production capacity and meeting the growing demand for biopharmaceuticals. This strategic move is likely to enhance Lonza's competitive edge by providing localized solutions and reducing time-to-market for clients. The facility is expected to incorporate advanced technologies, aligning with the industry's shift towards automation and efficiency. In September Charles River Laboratories (US) expanded its service offerings by acquiring a local biotech firm specializing in viral clearance testing. This acquisition is indicative of Charles River's strategy to enhance its capabilities and provide comprehensive solutions to its clients. By integrating local expertise, the company may strengthen its market position and improve its service delivery, which is crucial in a rapidly evolving market. In November Merck KGaA (DE) launched a new line of viral clearance products designed to meet the specific regulatory requirements of the South Korean market. This launch reflects Merck's commitment to innovation and its understanding of local market dynamics. By introducing tailored solutions, the company is likely to enhance its competitive positioning and attract a broader client base. As of November current trends in the viral clearance market include a strong emphasis on digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the competitive landscape, fostering collaboration that enhances innovation and operational efficiency. The shift from price-based competition to a focus on technological advancement and supply chain reliability is becoming increasingly evident. Companies that prioritize these aspects are likely to differentiate themselves in a crowded market, paving the way for sustained growth and success. ## Recent News & Developments The South Korea Viral Clearance Market has witnessed notable developments recently, particularly among key players such as SK Bioscience, Celltrion, and Samsung Biologics. In September 2023, SK Bioscience announced a partnership with Korea Vaccine to enhance their Research and Development capabilities, focusing on viral clearance technologies. Meanwhile, Celltrion is expanding its production capacity to meet the growing demand for biopharmaceuticals, further influencing market dynamics. Additionally, in July 2023, Medytox and Hanmi Pharmaceutical entered a strategic agreement to collaborate on innovative viral treatments, which is expected to bolster their market presence. In terms of mergers and acquisitions, Boryung Pharmaceutical announced in August 2023 their acquisition of Genexine’s antiviral program, aimed at advancing their product pipeline. The South Korean government continues to support the sector through funding initiatives and grants, driving growth in market valuation and setting a favorable regulatory environment for companies like LG Chem and Hugel to innovate and invest. The last two to three years have seen increased focus on bioprocessing improvements and novel viral clearance solutions amid the ongoing emphasis on public health safety, reshaping the competitive landscape of the market. ## Report Scope | MARKET SIZE 2024 | 17.6(USD Million) | | --- | --- | | MARKET SIZE 2025 | 21.47(USD Million) | | MARKET SIZE 2035 | 156.8(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 22.0% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Sartorius (DE), Merck KGaA (DE), Thermo Fisher Scientific (US), Charles River Laboratories (US), Lonza Group (CH), Boehringer Ingelheim (DE), Fujifilm Diosynth Biotechnologies (GB), KBI Biopharma (US) | | Segments Covered | Method, Application, End-user | | Key Market Opportunities | Advancements in filtration technologies enhance safety and efficacy in the viral clearance market. | | Key Market Dynamics | Rising demand for advanced viral clearance technologies driven by stringent regulatory standards and competitive market pressures. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What was the market valuation of the viral clearance market in 2024?** A: The market valuation of the viral clearance market was $17.6 Million in 2024. **Q: What is the projected market valuation for the viral clearance market by 2035?** A: The projected market valuation for the viral clearance market is $156.8 Million by 2035. **Q: What is the expected CAGR for the viral clearance market during the forecast period 2025 - 2035?** A: The expected CAGR for the viral clearance market during the forecast period 2025 - 2035 is 22.0%. **Q: Which companies are considered key players in the viral clearance market?** A: Key players in the viral clearance market include Sartorius, Merck KGaA, Thermo Fisher Scientific, Charles River Laboratories, Lonza Group, Boehringer Ingelheim, Fujifilm Diosynth Biotechnologies, and KBI Biopharma. **Q: What are the main methods used in viral clearance?** A: The main methods used in viral clearance include viral removal, viral inactivation, and viral detection, with valuations of $5.28 Million, $7.84 Million, and $4.48 Million respectively in 2024. **Q: What applications are driving the viral clearance market?** A: Applications driving the viral clearance market include blood and blood products, recombinant proteins, cellular & gene therapy products, and vaccines, with respective valuations of $3.52 Million, $4.2 Million, and $4.2 Million in 2024. **Q: What end-user segments are involved in the viral clearance market?** A: End-user segments in the viral clearance market include the pharmaceutical and biotech industry, academic research institutes, and CROs, with valuations of $7.04 Million, $3.52 Million, and $4.2 Million respectively in 2024. **Q: How does the viral inactivation method compare to other methods in terms of market valuation?** A: The viral inactivation method had a market valuation of $7.84 Million in 2024, indicating its prominence compared to other methods. **Q: What is the significance of the projected growth in the viral clearance market?** A: The projected growth in the viral clearance market suggests a robust expansion, with a potential increase to $156.8 Million by 2035. **Q: How do the valuations of different applications in the viral clearance market compare?** A: In 2024, the valuations of different applications in the viral clearance market varied, with recombinant proteins and vaccines both at $4.2 Million, while blood and blood products were at $3.52 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-viral-clearance-market-51849*